Friday , 24 January 2020

Review on Diabetic Retinopathy-An Update

Saritha Chandra*, Dugginaboina Dharani, RVS. Mounica
Jagan’s College of Pharmacy, Jangala Kandriga (V), Muthukur (M), SPSR Nellore-524348, A.P, India

ABSTRACT
Management of diabetes should involve both systemic and ocular aspects. Control of hyperglycemia, hypertension and dyslipidemia are of major role in the management of diabetic retinopathy. In the ocular part; laser treatment remains the cornerstone of treatment of diabetic macular edema (focal/grid), severe non-proliferative and proliferative diabetic retinopathy (panretinal photocoagulation). There is a strong support to combination therapy. Using one or two intravitreal injections such as anti-VEGF and or steroid to reduce central macular thickness followed by focal or grid laser to give a sustained response may offer an alternative to treatment in diabetic macular edema. Anti-VEGF were found to be effective as an adjunct therapy in proliferative diabetic retinopathy patient who is going to have vitrectomy for vitreous hemorrhage with neovascularization, panretinal photocoagulation, and other ocular surgery such as cases with neovascular glaucoma and cataract with refractory macular edema.

Keywords: Diabetic retinopathy, Pathophysiology, Management, Anti-VEGF, Steroids.

Scroll To Top